Unleashing the Power of Innovative Nanoparticles for Enhanced Radiation Therapy
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Nanomedicine and Nanobiology".
Deadline for manuscript submissions: 30 June 2025 | Viewed by 158
Special Issue Editor
Special Issue Information
Dear Colleagues,
Nanoparticles hold considerable promise in cancer research, offering innovative approaches for both diagnostics and treatment. Their varied morphologies and attributes—such as a high surface-to-volume ratio, enhanced cellular uptake, and remarkable versatility—facilitate the integration of diverse agents, including targeted molecules, drugs, nucleic acids, and antibodies. As a result, their capacity to invade tumors is substantially augmented, enhancing the precision and effectiveness of cancer treatment while minimizing unintended side effects.
Furthermore, the advent of nanoparticles has significantly advanced conventional radiation therapy, evolving it from a standardized approach into tailored and adaptive therapeutic strategies. Through their interaction with localized cancer cells, nanoparticles could enhance radiation sensitivity, yielding improved tumoricidal effects with reduced radiation doses, therefore showcasing their potential across diverse cancer treatment modalities.
This Special Issue aims to compile high-quality original research articles, reviews, and short communications from experts in the field, fostering collaboration and knowledge exchange among researchers dedicated to the application of nanoparticle-based radiation therapies to rectify the limitations of conventional radiation therapy.
Dr. Fangchao Jiang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomedicine
- drug delivery
- radiation therapy
- nanotheranostics
- nanoparticles
- cancer treatment
- biomaterial
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
